Showing results (81-90 of 826) with videos related to
Sort By:
Pageof 83
Pharmacological Reviews|April 5, 2025
Activating autophagy to eliminate toxic protein aggregates with small molecules in neurodegenerative diseasesYuqi Fu, Jin Zhang, Rui Qin, et al.Pharmacological Reviews|October 21, 2024
How to drug a cloud? Targeting intrinsically disordered proteinsVladimir N UverskyPharmacological Reviews|February 14, 2025
International Union of Basic and Clinical Pharmacology. CXVIII. Update on the nomenclature for atypical chemokine receptors, including ACKR5Andy Chevigné, Daniel F Legler, Antal Rot, et al.Pharmacological Reviews|February 14, 2025
Therapeutic advantage of combinatorial chimeric antigen receptor T cell and chemotherapiesMeghan B Ward, Amber B Jones, Giedre KrenciutePharmacological Reviews|February 14, 2025
Emerging pharmacotherapies for obesity: A systematic reviewMichail Kokkorakis, Marlene Chakhtoura, Caline Rhayem, et al.Pharmacological Reviews|June 24, 2024
Conotoxins Targeting Voltage-Gated Sodium Ion ChannelsShengrong Pei, Nan Wang, Zaoli Mei, et al.Pharmacological Reviews|March 3, 2007
International Union of Basic and Clinical Pharmacology. LXVII. Recommendations for the recognition and nomenclature of G protein-coupled receptor heteromultimersJean-Philippe Pin, Richard Neubig, Michel Bouvier, et al.Pharmacological Reviews|March 3, 2007
The endomorphin system and its evolving neurophysiological roleJakub Fichna, Anna Janecka, Jean Costentin, et al.Pharmacological Reviews|March 24, 2007
Neurotoxicity and metabolism of the catecholamine-derived 3,4-dihydroxyphenylacetaldehyde and 3,4-dihydroxyphenylglycolaldehyde: the role of aldehyde dehydrogenaseSatori A Marchitti, Richard A Deitrich, Vasilis VasiliouPharmacological Reviews|September 14, 2006
Cyclic nucleotide phosphodiesterases: molecular regulation to clinical useAndrew T Bender, Joseph A BeavoPageof 83